The American Diabetes Association Welcomes New Leadership for 2026 Board of Directors
The American Diabetes Association (ADA) proudly announced its newly appointed board of directors for the year 2026. This distinguished 15-member board includes a diverse group of professionals, each bringing unique expertise in medicine, science, education, and business leadership. Their collaborative goal is to continue the ADA's century-long mission of combating diabetes while enhancing health equity across communities.
CEO Charles "Chuck" Henderson expressed excitement about the new board's potential. "We are thrilled to welcome our 2026 board of directors," he emphasized. "Their collective experience and passion will undoubtedly contribute to our fight against diabetes and its associated challenges." The announcement also honored outgoing board members Francisco Prieto, MD, and Gretchen Youssef, MS, RD, CDCES, acknowledging their invaluable contributions.
Each principal officer brings significant experience and vision to their roles. James Tai, who is serving as Chair, has a rich background in health care and entrepreneurship. He has been pivotal in the ADA's Innovation Committee, working on enhancing the ADA Innovation Fund's capabilities to address diabetes and obesity challenges.
Mario Rivera, the Secretary/Treasurer, has experience leading large health care operations. He recently transformed CVS Health’s supply chain, underscoring his strategic and operational expertise that is essential for the ADA's financial health.
Medical and scientific leadership comes from Dr. Enrique Caballero, who directs innovation programs at Harvard Medical School and has a profound commitment to health disparities. In contrast, Amy Hess-Fischl, as President of Health Care Education, has focused on diabetes education and management, promoting accessible diabetes education across all life stages.
The elect officers for 2026 further enhance the leadership team. Sean Pittman, who heads the Pittman Law Group, underscores the importance of legal and governmental insight in health advocacy. He has a storied history of leadership across educational and civic organizations.
Dr. John (Wig) Wigneswaran leads as the Secretary/Treasurer-Elect, bringing vast clinical experience to the role, while Dr. Jennifer Green, the President-Elect for Medicine & Science, is recognized for her groundbreaking diabetes research. Dr. Elizabeth Beverly, focused on health care education, leads initiatives on psychosocial factors in diabetes management.
The remaining members of the board, including professionals from various healthcare sectors, enhance the ADA's broad spectrum of expertise. From clinical care to health policy, they are dedicated to advancing the ADA's mission in diabetes research, advocacy, and community support.
James Tai summed up the spirit of the new board by saying, "Together, the members of this board bring tremendous expertise and dedication to our mission. Their leadership will propel advancements in diabetes research, education, and advocacy across the country."
The American Diabetes Association, the leading health organization dedicated to fighting diabetes, officially celebrates its 85th anniversary this year. With an estimated 136 million Americans living with diabetes or prediabetes, their mission remains critical. For more information on their initiatives and to learn how to get involved, the ADA encourages everyone to visit diabetes.org.
This announcement is more than just a leadership transition; it signifies a renewed commitment to the fight against diabetes and the continuous journey towards improved health outcomes for all affected individuals. As the board begins its tenure, it carries with it the hopes and expectations of millions across the nation grappling with the challenges of this condition.
The ADA’s determination to end diabetes continues to thrive, supported by not only their new board but also the collective efforts of advocates, researchers, and healthcare professionals nationwide.
CEO Charles "Chuck" Henderson expressed excitement about the new board's potential. "We are thrilled to welcome our 2026 board of directors," he emphasized. "Their collective experience and passion will undoubtedly contribute to our fight against diabetes and its associated challenges." The announcement also honored outgoing board members Francisco Prieto, MD, and Gretchen Youssef, MS, RD, CDCES, acknowledging their invaluable contributions.
Each principal officer brings significant experience and vision to their roles. James Tai, who is serving as Chair, has a rich background in health care and entrepreneurship. He has been pivotal in the ADA's Innovation Committee, working on enhancing the ADA Innovation Fund's capabilities to address diabetes and obesity challenges.
Mario Rivera, the Secretary/Treasurer, has experience leading large health care operations. He recently transformed CVS Health’s supply chain, underscoring his strategic and operational expertise that is essential for the ADA's financial health.
Medical and scientific leadership comes from Dr. Enrique Caballero, who directs innovation programs at Harvard Medical School and has a profound commitment to health disparities. In contrast, Amy Hess-Fischl, as President of Health Care Education, has focused on diabetes education and management, promoting accessible diabetes education across all life stages.
The elect officers for 2026 further enhance the leadership team. Sean Pittman, who heads the Pittman Law Group, underscores the importance of legal and governmental insight in health advocacy. He has a storied history of leadership across educational and civic organizations.
Dr. John (Wig) Wigneswaran leads as the Secretary/Treasurer-Elect, bringing vast clinical experience to the role, while Dr. Jennifer Green, the President-Elect for Medicine & Science, is recognized for her groundbreaking diabetes research. Dr. Elizabeth Beverly, focused on health care education, leads initiatives on psychosocial factors in diabetes management.
The remaining members of the board, including professionals from various healthcare sectors, enhance the ADA's broad spectrum of expertise. From clinical care to health policy, they are dedicated to advancing the ADA's mission in diabetes research, advocacy, and community support.
James Tai summed up the spirit of the new board by saying, "Together, the members of this board bring tremendous expertise and dedication to our mission. Their leadership will propel advancements in diabetes research, education, and advocacy across the country."
The American Diabetes Association, the leading health organization dedicated to fighting diabetes, officially celebrates its 85th anniversary this year. With an estimated 136 million Americans living with diabetes or prediabetes, their mission remains critical. For more information on their initiatives and to learn how to get involved, the ADA encourages everyone to visit diabetes.org.
This announcement is more than just a leadership transition; it signifies a renewed commitment to the fight against diabetes and the continuous journey towards improved health outcomes for all affected individuals. As the board begins its tenure, it carries with it the hopes and expectations of millions across the nation grappling with the challenges of this condition.
The ADA’s determination to end diabetes continues to thrive, supported by not only their new board but also the collective efforts of advocates, researchers, and healthcare professionals nationwide.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.